Polyrizon Ltd. (NASDAQ:PLRZ – Get Free Report) traded up 3.1% on Monday . The stock traded as high as $13.46 and last traded at $13.25. 58,900 shares traded hands during trading, a decline of 37% from the average session volume of 93,828 shares. The stock had previously closed at $12.85.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Polyrizon in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.
View Our Latest Research Report on PLRZ
Polyrizon Trading Up 3.1%
Polyrizon Company Profile
Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.
Featured Articles
- Five stocks we like better than Polyrizon
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.
